HIV Drugs Market to Grow with a Significant CAGR During the forecast period 2022-2030

The global HIV drugs market peaked at ~US$ 30.89 billion in 2021. The market is expected to witness a CAGR of ~6.25 from 2022 to 2030.

Increasing HIV/AIDS prevalence especially in low and middle-income countries is one of the major factors in boosting the global HIV drugs market. The number of people receiving HIV treatment is increasing as they are becoming more aware of the infection and its drug treatment options. In addition, the development of HIV therapeutics and medical trials, and product launches are the factors driving the growth of the market. Also, the government initiatives in creating awareness amongst the population to prevent and manage HIV to reduce the economic burden is further supporting the HIV drugs market expansion.

According to World Health Organization (WHO) 2021 report, currently, around 38.4 million individuals are infected with HIV worldwide. And it has also been estimated that around 1.5 million people acquired HIV in 2021. Although the rate has declined over the last few decades still, a large part of this infected population is living with unmet needs for HIV care. This has led to governments of various economies especially the low emerging to take initiatives and create awareness to adopt HIV therapy. India for instance is the third largest economy with HIV cases in the world. The government of India has taken various initiatives to support HIV/AIDS affected individuals. The National AIDS Control Program was launched in 1992 by the National AIDS Control Organization (NACO) under the Ministry of Health and Family Welfare. This body has recently taken new strategic steps to reduce HIV cases and further support the rights and fulfill the unmet needs of HIV/AIDS-affected individuals. Thus, such steps by the governments and CSR activities are expected to boost the global HIV drugs market.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/hiv-drugs-market/7792

Key Players Mentioned in the HIV Drugs Market:

• Mylan N.V.
• AbbVie Inc.
• Bristol-Myers Squibb Company
• ViiV Healthcare Limited
• Genentech, Inc.
• Gilead Sciences, Inc.
• Merck & Co.
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline plc
• Janssen Pharmaceuticals, Inc.

HIV Drugs Market by Drug Class

• Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
• Integrase Inhibitors
• Combination Drugs

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the HIV Drugs Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global HIV Drugs Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the HIV Drugs Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

TOC of Global HIV Drugs Market

1 Scope of the Report

1.1 Market Ecosystem
1.2 Geographic Scope
1.3 Timeline Under Consideration
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 HIV Drugs Market Executive Summary

2.1 World Market Overview
2.1.1 Global Market Size 2021-2031
2.1.2 Market Size CAGR by Region 2020 VS 2028
2.2 HIV Drugs Market Segment by Type
2.2.1 Type 1
2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/hiv-drugs-market/7792

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.